Stay up to date with news and events
2025 HDBuzz Prize: On the Frontlines: Trusting the Hall Monitors of the Cell
October 2, 2025
Think about the last time you were stressed. What did you do to feel better? For many of us, it’s talking through our frustrations. Getting…
September 2025: This Month in Huntington’s Disease Research
September 30, 2025
This month brought landmark therapeutic news, advances in biomarkers, deeper insights into what drives Huntington’s disease (HD), and fresh perspectives on mental health in HD….
The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial
September 24, 2025
UniQure has announced positive top-line results from its Phase I/II trial of AMT-130, a one-time gene therapy being tested in people with Huntington’s disease (HD)….
2025 HDBuzz Prize: When the Repair Crew Breaks Down: How Expanded Huntingtin Disrupts DNA Repair
September 22, 2025
Every cell in our body is constantly fixing DNA damage that happens throughout our lifetime. Like a city sending out crews to mend roads and power lines,…
SKY-0515 Lowers Huntingtin In People With Huntington’s Disease In Trial Update
September 19, 2025
On September 17, 2025, we received an encouraging update from Skyhawk Therapeutics’ Phase 1 study, taking place in Australia. The recent update suggests that SKY-0515…